Skin cancer vaccine BLA submitted by...? — June 30, 2027?
87% chance
- Resolves
- Jun 30, 2027
- Volume
- $86.2K
- 24h
- $0
- Liquidity
- $8.0K
Listed on 1 venueChance over time
Yes price, by venuePolymarket USCFTC-regulatedDeposit $10, get $25
Trading bonus for new sign-ups.
Sponsored · We may earn a commission · 18+ · Trade responsibly · 1-800-GAMBLER
Signals
Quiet market: no big moves or venue gaps in the last 24 hours.
Every venue’s price
1 venueEach share pays $1 if it’s right. Green marks the cheapest venue after fees; every price opens that venue’s market.
Before you trade
How each venue settles it
Polymarket (global)
This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by June 30, 2027, 11:59 PM ET. Otherwise, this market will resolve to "No". Intismeran autogene refers to the individualized neoantigen therapy developed by Mod…
Full rules on Polymarket (global) ↗About this market
- Category
- Culture
- Resolves
- Wed, June 30, 2027
Compared across 1 venueIn the news
Discussion
Sign in to join the discussion
Sign In